Description: Cogstate is a leading cognitive science company focused on optimizing the measurement of cognition to guide decision-making in clinical trials, academic research and healthcare. Cogstate commercializes rapid, reliable and highly sensitive computerized cognitive tests and provides expert support for traditional neurological assessments. Our products and services have been used in hundreds of clinical trials, guiding decision-making for cognitive safety and efficacy across many indications and all phases of development. Cogstate’s unique combination of science, service and technology allows us to deliver solutions to the most pressing challenges for reliable clinical assessments of cognition.
Home Page: www.cogstate.com
367 Collins Street
Melbourne,
VIC
3000
Australia
Phone:
61 3 9664 1300
Officers
| Name | Title |
|---|---|
| Mr. Bradley John O'Connor B.Bus, C.A., CA | CEO, MD & Executive Director |
| Mr. Darren Watson | Chief Financial Officer |
| Ms. Rachel Colite | Executive VP of Clinical Trials |
| Prof. Paul Maruff BBSc (Hons), Ph.D. | Founder & Chief Innovation Officer |
| Ms. Kristi Geddes | General Counsel, Joint Company Secretary & Director |
| Mr. Kenneth Billard | Chief Commercial Officer |
| Dr. Kaycee Sink M.D. | Chief Medical Officer |
| Mr. David James Franks BEc, C.A., F Fin, J.P. | Joint Company Secretary |
Exchange: OTCQX
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 24.4499 |
|---|---|
| Trailing PE: | 24.3667 |
| Price-to-Book MRQ: | 2.9549 |
| Price-to-Sales TTM: | 3.1384 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 160 |